AcelRx Pharmaceuticals, Inc.

Welcome to the AccelRx third quarter 2022 earnings call. This call is being webcast live via the events page of the investor section of AccelRx's website at www.accelrx.com. This call is the property of AccelRx. And any recording, reproduction, or transmission of this call without the express written consent of AccelRx is strictly prohibited. As a reminder, today's webcast presentation is being recorded. You may listen to a replay of this webcast by going to the investor section of ExcelRx's website. I would now like to turn the call over to Rafi Azadorian, ExcelRx Chief Financial Officer.

Thank you for joining us on the call today.

This afternoon, we announced our third quarter 2022 financial results and associated business updates in a press release. This press release can be found within the Investors section of our website. With me today are Vince Angotti, our Chief Executive Officer, and Dr. Pam Palmer, Accelerex's founder and Chief Medical Officer. Before we begin, I want to remind listeners that during this call, we will make forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Accelerex. Please refer to our press release in addition to the company's periodic, current, and annual reports filed with the Securities and Exchange Commission for a discussion of the risks associated with such forward-looking statements. I will now hand the call over to Vince.